{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T04:08:34Z","timestamp":1791950914950,"version":"4.3.4"},"update-to":[{"DOI":"10.1002\/14651858.cd006501","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2008,10,8]],"date-time":"2008-10-08T00:00:00Z","timestamp":1223424000000}}],"reference-count":105,"publisher":"Wiley","issue":"3","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd006501.pub2","type":"journal-article","created":{"date-parts":[[2008,10,9]],"date-time":"2008-10-09T01:07:07Z","timestamp":1223514427000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":36,"title":["Immunoglobulin prophylaxis in hematological malignancies and hematopoietic stem cell transplantation"],"prefix":"10.1002","volume":"2024","author":[{"given":"Pia","family":"Raanani","sequence":"additional","affiliation":[{"name":"Institute of Hematology, Davidoff Center; Beilinson Hospital, Rabin Medical Center; Petah Tikva Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anat","family":"Gafter-Gvili","sequence":"additional","affiliation":[{"name":"Department of Medicine E; Beilinson Hospital, Rabin Medical Center; Petah Tikva Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mical","family":"Paul","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases; Rambam Health Care Campus; Haifa Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isaac","family":"Ben-Bassat","sequence":"additional","affiliation":[{"name":"Sackler School of Medicine; Tel Aviv University; Tel Aviv Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonard","family":"Leibovici","sequence":"additional","affiliation":[{"name":"Department of Medicine E; Beilinson Hospital, Rabin Medical Center; Petah Tikva Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ofer","family":"Shpilberg","sequence":"additional","affiliation":[{"name":"Institute of Hematology, Davidoff Center; Beilinson Hospital, Rabin Medical Center; Petah Tikva Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2008,10,8]]},"reference":[{"issue":"9","key":"10.1002\/14651858.CD006501.pub2-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1038\/sj.bmt.1701742","article-title":"Comparison of two doses of intravenous immunoglobulin after allogeneic bone marrow transplants","volume":"23","author":"Abdel-Mageed","year":"1999","journal-title":"Bone marrow transplantation"},{"issue":"7","key":"10.1002\/14651858.CD006501.pub2-BIB0002|cit2","first-page":"343","article-title":"Randomized, placebo-controlled, double-blind study of a cytomegalovirus-specific monoclonal antibody (MSL-109) for prevention of cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation","volume":"1","year":"2001","journal-title":"Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation"},{"issue":"5","key":"10.1002\/14651858.CD006501.pub2-BIB0003|cit3","first-page":"289","article-title":"[Clinical and biological evaluation of the preventive role of anti-cytomegalovirus specific immunoglobulins in bone marrow grafts. Randomized study of 60 patients]","volume":"29","year":"1987","journal-title":"Nouvelle revue fran?aise d'hematologie"},{"issue":"1","key":"10.1002\/14651858.CD006501.pub2-BIB0004|cit4","first-page":"75","article-title":"Randomized trial of intravenous immunoglobulin prophylaxis for patients with chronic lymphocytic leukaemia and secondary hypogammaglobulinaemia","volume":"17","year":"1995","journal-title":"Clinical and laboratory haematology"},{"issue":"16","key":"10.1002\/14651858.CD006501.pub2-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1056\/NEJM198604173141602","article-title":"ytomegalovirus immune globulin and seronegative blood products to prevent primary cytomegalovirus infection after marrow transplantation","volume":"314","author":"Bowden","year":"1986","journal-title":"The New England journal of medicine"},{"issue":"3","key":"10.1002\/14651858.CD006501.pub2-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1093\/infdis\/164.3.483","article-title":"Cytomegalovirus (CMV)-specific intravenous immunoglobulin for the prevention of primary CMV infection and disease after marrow transplant","volume":"164","year":"1991","journal-title":"The Journal of infectious diseases"},{"issue":"8905","key":"10.1002\/14651858.CD006501.pub2-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/S0140-6736(94)90180-5","article-title":"Randomised trial of intravenous immunoglobulin as prophylaxis against infection in plateau-phase multiple myeloma. The UK Group for Immunoglobulin Replacement Therapy in Multiple Myeloma","volume":"343","year":"1994","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD006501.pub2-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/j.1365-2141.1994.tb05002.x","article-title":"Immunoglobulin replacement in patients with chronic lymphocytic leukaemia: a comparison of two dose regimes","volume":"88","year":"1994","journal-title":"British journal of haematology"},{"issue":"3A","key":"10.1002\/14651858.CD006501.pub2-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/0002-9343(84)90332-2","article-title":"Prevention of cytomegalovirus infection by prophylaxis with an intravenous, hyperimmune, native, unmodified cytomegalovirus globulin. Randomized trial in bone marrow transplant recipients","volume":"76","author":"Condie","year":"1984","journal-title":"The American journal of Medicine"},{"issue":"1","key":"10.1002\/14651858.CD006501.pub2-BIB0010|cit10","first-page":"1405","article-title":"A randomized trial of intravenous hyperimmune globulin for the prevention of CMV infections following marrow transplantation: preliminary results","volume":"XV","year":"1983","journal-title":"Transplantation proceedings"},{"issue":"14","key":"10.1002\/14651858.CD006501.pub2-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1056\/NEJM198810063191403","article-title":"Intravenous immunoglobulin for the prevention of infection in chronic lymphocytic leukemia. A randomized, controlled clinical trial. Cooperative Group for the Study of Immunoglobulin in Chronic Lymphocytic Leukemia","volume":"319","author":"Cooperative Group for the Study of Immunoglobulin in Chronic Lymphocytic Leukemia","year":"1988","journal-title":"The New England journal of medicine"},{"issue":"2","key":"10.1002\/14651858.CD006501.pub2-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1182\/blood.V73.2.366.366","article-title":"Crossover study of immunoglobulin replacement therapy in patients with low-grade B-cell tumors","volume":"73","year":"1989","journal-title":"Blood"},{"issue":"1","key":"10.1002\/14651858.CD006501.pub2-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"8","DOI":"10.7326\/0003-4819-139-1-200307010-00007","article-title":"Should immunoglobulin therapy be used in allogeneic stem-cell transplantation? A randomized, double-blind, dose effect, placebo-controlled, multicenter trial","volume":"139","author":"Cordonnier","year":"2003","journal-title":"Annals of internal medicine"},{"key":"10.1002\/14651858.CD006501.pub2-BIB0014|cit14","unstructured":"Emanuel D Taylor J Brochstein J Kernan N Boulad F Laver J Castro-Malaspina H Young J Papadopoulos E Carabasi M Childs B Flomenberg M O'Reilly R The use of intravenous immune globulin as prophylaxis for the infectious complications of allogeneic marrow transplantation Blood 1992 271a"},{"issue":"6","key":"10.1002\/14651858.CD006501.pub2-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/S1083-8791(99)70013-3","article-title":"Reduced dose intravenous immunoglobulin does not decrease transplant-related complications in adults given related donor marrow allografts","volume":"5","year":"1999","journal-title":"Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation"},{"key":"10.1002\/14651858.CD006501.pub2-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"2656","DOI":"10.1182\/blood.V80.10.2656.2656","article-title":"Circulating cytomegalovirus (CMV) neutralizing activity in bone marrow transplant recipients: comparison of passive immunity in a randomized study of four intravenous IgG products administered to CMV-seronegative patients","volume":"80","year":"1992","journal-title":"Blood"},{"key":"10.1002\/14651858.CD006501.pub2-BIB0017|cit17","unstructured":"Prophylactic intravenous immunoglobulin (IVIG) application to patients with recurrent infections and secondary antibody deficiency due to B-cell neoplasia Blut 1990 140"},{"issue":"suppl 2","key":"10.1002\/14651858.CD006501.pub2-BIB0018|cit18","first-page":"132","article-title":"Preventing systemic infections with IVIG: a randomized multicenter trial","volume":"5","year":"1990","journal-title":"Bone Marrow Transplantation"},{"key":"10.1002\/14651858.CD006501.pub2-BIB0019|cit19","unstructured":"Holt J Bunch C Reid C Griffiths H Infection, immune response and intravenous immunoglobulin infection prophylaxis in myeloma British journal of cancer 1992 66 suppl XVII Abstract O40 11"},{"issue":"2-3","key":"10.1002\/14651858.CD006501.pub2-BIB0020|cit20","first-page":"193","article-title":"Intravenous hyperimmune globulin prophylaxis against cytomegalovirus interstitial pneumonitis after allogenic bone marrow transplantation","volume":"10","year":"1985","journal-title":"The Tokai journal of experimental and clinical medicine"},{"key":"10.1002\/14651858.CD006501.pub2-BIB0021|cit21","first-page":"468","article-title":"Preliminary data of a controlled trial of interavenous hyperimmune globulin in the prevention of cytomegalovirus infection in bone marrow transplant recipients","volume":"XVII","author":"Ernst","year":"1985","journal-title":"Transplantation proceedings"},{"key":"10.1002\/14651858.CD006501.pub2-BIB0022|cit22","unstructured":"Lum L Bitonti O Galoforo S Walker A Lum C Abella E Babington R Karenes C Momim F Uberti J Ratanatharathorn V Sensenbrenner L Intravenous gammaglobulin (IVIG) does not alter immune parameters in a randomized trial after bone marrow transplantation (BMT) Experimental hematology 1994 680"},{"key":"10.1002\/14651858.CD006501.pub2-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"442","DOI":"10.7326\/0003-4819-98-4-442","article-title":"Prevention of cytomegalovirus infection by cytomegalovirus immune globulin after marrow transplantation","volume":"98","year":"1983","journal-title":"Annals of internal medicine"},{"issue":"2","key":"10.1002\/14651858.CD006501.pub2-BIB0024|cit24","first-page":"121","article-title":"Prophylaxis against infections with low-dose intravenous immunoglobulins (IVIG) in chronic lymphocytic leukemia. Results of a crossover study","volume":"81","author":"Molica","year":"1996","journal-title":"Haematologica"},{"issue":"4","key":"10.1002\/14651858.CD006501.pub2-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1111\/j.1365-2141.1995.tb08447.x","article-title":"Prophylaxis against infections with intravenous immunoglobulins in multiple myeloma","volume":"89","year":"1995","journal-title":"British journal of haematology"},{"key":"10.1002\/14651858.CD006501.pub2-BIB0026|cit26","first-page":"112","article-title":"Randomized double-blinded comparison of three intravenous immunoglobulin products in bone marrow transplantation","volume":"29","author":"Peltier","year":"1992","journal-title":"Seminars in hematology"},{"issue":"9","key":"10.1002\/14651858.CD006501.pub2-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1111\/j.1365-2362.1993.tb00963.x","article-title":"Effect of IgM-enriched intravenous immunoglobulin (Pentaglobin) on endotoxaemia and anti-endotoxin antibodies in bone marrow transplantation","volume":"23","year":"1993","journal-title":"European journal of clinical investigation"},{"key":"10.1002\/14651858.CD006501.pub2-BIB0028|cit28","first-page":"451","article-title":"Use of IgM enriched intravenous immunoglobulin (Pentaglobin) in bone marrow transplantation","volume":"9","author":"Poynton","year":"1992","journal-title":"Bone marrow transplantation"},{"key":"10.1002\/14651858.CD006501.pub2-BIB0029|cit29","unstructured":"Raiola AM Di Grazia C Dominietto A Bregante S Gualandi F Lamparelli T Occhini D Van Lint MT Bacigalupo A Prevention of graft versus host disease with IgM enriched immunoglobulins: a preliminary analysis of a randomized study [abstract] Bone Marrow Transplantation 2002 S188"},{"issue":"3","key":"10.1002\/14651858.CD006501.pub2-BIB0030|cit30","first-page":"299","article-title":"Failure to prevent cytomegalovirus infection by cytomegalovirus hyperimmune plasma: a randomized trial by the Nordic Bone Marrow Transplantation Group","volume":"2","year":"1987","journal-title":"Bone Marrow Transplantation"},{"issue":"3","key":"10.1002\/14651858.CD006501.pub2-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/sj.bmt.1700649","article-title":"No prevention of cytomegalovirus infection by anti-cytomegalovirus hyperimmune globulin in seronegative bone marrow transplant recipients. The Nordic BMT Group","volume":"19","year":"1997","journal-title":"Bone marrow transplantation"},{"key":"10.1002\/14651858.CD006501.pub2-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1056\/NEJM196712212772503","article-title":"Role of gamma globulin for immunoprophylaxis in multiple myeloma","volume":"277","year":"1967","journal-title":"The New England journal of medicine"},{"issue":"1","key":"10.1002\/14651858.CD006501.pub2-BIB0033|cit33","first-page":"1","article-title":"A randomized trial to determine the utility of intravenous hyperimmune immunoglobulin in antimicrobial prophylaxis and its immunomodulatory effect in allogeneic bone marrow transplantation hyperimmune immunoglobulin in antimicrobial prophylaxis and its immunomodulatory effect in allogeneic bone marrow transplantation","volume":"10","year":"1999","journal-title":"Transplantology (Madrid)"},{"key":"10.1002\/14651858.CD006501.pub2-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1159\/000227231","article-title":"Effect of various doses of intravenous polyclonal IgG on in vivo levels of 12 pneumococcal antibodies in patients with chronic lymphocytic leukaemia and multiple myeloma","volume":"50","year":"1993","journal-title":"Oncology"},{"issue":"11","key":"10.1002\/14651858.CD006501.pub2-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1056\/NEJM199009133231103","article-title":"Immunomodulatory and antimicrobial efficacy of intravenous immunoglobulin in bone marrow transplantation","volume":"323","year":"1990","journal-title":"The New England journal of Medicine"},{"key":"10.1002\/14651858.CD006501.pub2-BIB0036|cit36","unstructured":"Intravenous immunoglobulin (IVIG) prophylaxis in unrelated ddonor bone marrow transplantation(BMT): a phase III double-blind, Placebo-controlled multi-institutional trial ASCO annual meeting abstract book 2000 abstract 181"},{"issue":"10 Suppl1 (Pt 2","key":"10.1002\/14651858.CD006501.pub2-BIB0037|cit37","first-page":"355b, abstract","article-title":"Clinical effects of intravenous immune globulin (IVIG)treatment in patients with allogenetic peripheral stem cell transplantation","volume":"92","year":"1998","journal-title":"Blood"},{"issue":"1","key":"10.1002\/14651858.CD006501.pub2-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"11","DOI":"10.7326\/0003-4819-97-1-11","article-title":"Cytomegalovirus immune plasma in bone marrow transplant recipients","volume":"97","year":"1982","journal-title":"Annals of internal medicine"},{"issue":"3A","key":"10.1002\/14651858.CD006501.pub2-BIB0039|cit39","first-page":"128","article-title":"Intravenous immunoglobulin for modification of cytomegalovirus infections associated with bone marrow transplantation. Preliminary results of a controlled trial","volume":"76","year":"1984","journal-title":"The American journal of medicine"},{"key":"10.1002\/14651858.CD006501.pub2-BIB0040|cit40","first-page":"296","article-title":"Use of a polyvalent intravenous immunoglobulin or specific cytomegalovirus hyperimmunoglobulin for modification of cytomegalovirus infections and prevention of interstitial pneumonias following bone marrow transplantation","volume":"13","author":"Winston","year":"1985","journal-title":"Immunitat und Infektion"},{"issue":"1","key":"10.1002\/14651858.CD006501.pub2-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"12","DOI":"10.7326\/0003-4819-106-1-12","article-title":"Intravenous immune globulin for prevention of cytomegalovirus infection and interstitial pneumonia after bone marrow transplantation","volume":"106","year":"1987","journal-title":"Annals of internal medicine"},{"issue":"3","key":"10.1002\/14651858.CD006501.pub2-BIB0042|cit42","first-page":"283","article-title":"Intravenous immunoglobulin and CMV-seronegative blood products for prevention of CMV infection and disease in bone marrow transplant recipients","volume":"12","year":"1993","journal-title":"Bone marrow transplantation"},{"issue":"2","key":"10.1002\/14651858.CD006501.pub2-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/sj.bmt.1703109","article-title":"A multicenter, randomized, double-blind comparison of different doses of intravenous immunoglobulin for prevention of graft-versus-host disease and infection after allogeneic bone marrow transplantation","volume":"28","year":"2001","journal-title":"Bone marrow transplantation"},{"issue":"12","key":"10.1002\/14651858.CD006501.pub2-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"937","DOI":"10.7326\/0003-4819-118-12-199306150-00004","article-title":"High-dose weekly intravenous immunoglobulin to prevent infections in patients undergoing autologous bone marrow transplantation or severe myelosuppressive therapy. A study of the American Bone Marrow Transplant Group","volume":"118","author":"Wolff","year":"1993","journal-title":"Annals of internal medicine"},{"issue":"2","key":"10.1002\/14651858.CD006501.pub2-BIB0045|cit45","first-page":"132","article-title":"A randomized trial of high dose polyvalent intravenous immunoglobulin (HDIgG) vs. Cytomegalovirus (CMV) hyperimmune IgG in allogeneic hemopoietic stem cell transplants (HSCT)","volume":"83","year":"1998","journal-title":"Haematologica"},{"issue":"6","key":"10.1002\/14651858.CD006501.pub2-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1093\/infdis\/163.6.1344","article-title":"Human monoclonal antibodies neutralizing cytomegalovirus (CMV) for prophylaxis of CMV disease: report of a phase I trial in bone marrow transplant recipients","volume":"163","year":"1991","journal-title":"The Journal of infectious diseases"},{"issue":"6","key":"10.1002\/14651858.CD006501.pub2-BIB0047|cit47","first-page":"476","article-title":"Immunoglobulin administration as infection prevention in oncologic patients","volume":"198","year":"1986","journal-title":"Klinische P?diatrie"},{"issue":"5-6","key":"10.1002\/14651858.CD006501.pub2-BIB0048|cit48","first-page":"419","article-title":"Immunoglobulin replacement in chronic lymphocytic leukaemia","volume":"30","year":"1988","journal-title":"Nouvelle Revue Francaise d'Hematologie"},{"issue":"1","key":"10.1002\/14651858.CD006501.pub2-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/BF00918268","article-title":"Immunoglobulin replacement in patients with chronic lymphocytic leukemia (CLL):kinetics of immunoglobulin metabolism","volume":"12","author":"Chapel","year":"1992","journal-title":"Journal of clinical immunology"},{"issue":"1-4","key":"10.1002\/14651858.CD006501.pub2-BIB0050|cit50","first-page":"77","article-title":"Intravenous immunoglobulin therapy in patients with multiple myeloma","volume":"4","year":"1993","journal-title":"Immunodeficiency"},{"key":"10.1002\/14651858.CD006501.pub2-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"25","DOI":"10.3109\/10428199109064875","article-title":"A pilot study using intravenous immunoglobulin for the prevention of infection during remission induction in acute leukaemia","volume":"6","year":"1991","journal-title":"Leukemia & lymphoma"},{"key":"10.1002\/14651858.CD006501.pub2-BIB0052|cit52","unstructured":"Intravenous immunoglobulin for infection prophylaxis in acute leukemia British Journal of Haemaology 1991 75"},{"key":"10.1002\/14651858.CD006501.pub2-BIB0053|cit53","first-page":"87","article-title":"Controlled trial of orally administered immunoglobulin following bone marrow transplantation","volume":"13","year":"1994","journal-title":"Bone marrow transplantation"},{"key":"10.1002\/14651858.CD006501.pub2-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1086\/342412","article-title":"Immune-globulin prophylaxis of respiratory syncytial virus infection in patients undergoing stem-cell transplantation","volume":"186","year":"2002","journal-title":"The Journal of infectious diseases"},{"key":"10.1002\/14651858.CD006501.pub2-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"165","DOI":"10.7326\/0003-4819-135-3-200108070-00008","article-title":"The effect of two different dosages of intravenous immunoglobulin on the incidence of recurrent infections in patients with primary hypogammaglobulinemia. A randomized, double-blind, multicenter crossover trial","volume":"135","year":"2001","journal-title":"Annals of internal medicine"},{"issue":"1","key":"10.1002\/14651858.CD006501.pub2-BIB0056|cit56","first-page":"3099","article-title":"Interim results of a multicenter trial to prevent cytomegalovirus pneumonia after allogeneic bone marrow transplantation","volume":"21","year":"1989","journal-title":"Transplantation proceedings"},{"key":"10.1002\/14651858.CD006501.pub2-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1097\/01.TP.0000129409.84087.62","article-title":"Predicting the costs of allogeneic sibling stem-cell transplantation: results from a prospective, multicenter, French study","volume":"77","year":"2004","journal-title":"Transplantation"},{"issue":"1 Pt 3","key":"10.1002\/14651858.CD006501.pub2-BIB0058|cit58","first-page":"3107","article-title":"Immune globulin (GAMMAGARD) prophylaxis of CMV infections in patients undergoing organ transplantation and allogeneic bone marrow transplantation","volume":"21","year":"1989","journal-title":"Transplantation proceedings"},{"key":"10.1002\/14651858.CD006501.pub2-BIB0059|cit59","first-page":"17","article-title":"Intravenous immune globulin in chronic lymphocytic leukaemia","volume":"97 Suppl 1","year":"1994","journal-title":"Clinical and experimental immunology"},{"issue":"4","key":"10.1002\/14651858.CD006501.pub2-BIB0060|cit60","first-page":"323","article-title":"[Prevention of cytomegalic inclusion disease in leukemia patients with a cytomegalovirus hyperimmune globulin preparation]","volume":"201","year":"1989","journal-title":"Klinische P?diatrie"},{"issue":"2","key":"10.1002\/14651858.CD006501.pub2-BIB0061|cit61","first-page":"115","article-title":"Immunoglobulin prophylaxis during intensive treatment of acute lymphoblastic leukemia in children","volume":"32","year":"1992","journal-title":"Acta Paediatrica Hungarica"},{"key":"10.1002\/14651858.CD006501.pub2-BIB0062|cit62","first-page":"559","article-title":"Intravenous immunoglobulin may lessen all forms of infection in patients receiving allogeneic bone marrow transplantation for acute lymphoblastic leukemia: a pediatric oncology group study","volume":"3","year":"1988","journal-title":"Bone marrow transplantation"},{"issue":"2","key":"10.1002\/14651858.CD006501.pub2-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1111\/j.1600-0609.1994.tb01874.x","article-title":"Treatment of hypogammaglobulinaemia in chronic lymphocytic leukaemia by low-dose intravenous gammaglobulin","volume":"53","author":"Jurlander","year":"1994","journal-title":"European journal of haematology"},{"issue":"6","key":"10.1002\/14651858.CD006501.pub2-BIB0064|cit64","first-page":"3536","article-title":"Intravenous immunoglobulin: immune modulatory effects in vitro and clinical effects in allogeneic bone marrow transplant recipients","volume":"27","year":"1995","journal-title":"Transplantation proceedings"},{"issue":"2","key":"10.1002\/14651858.CD006501.pub2-BIB0065|cit65","first-page":"163","article-title":"Efficacy of hyperimmune anti-cytomegalovirus immunoglobulins for the prevention of cytomegalovirus infection in recipients of allogeneic bone marrow transplantation: a meta-analysis","volume":"13","year":"1994","journal-title":"Bone marrow transplantation"},{"issue":"1","key":"10.1002\/14651858.CD006501.pub2-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1046\/j.1365-3083.1999.00555.x","article-title":"Prophylactic intravenous immunoglobulin treatment influences serum immunoglobulin M repertoire development after allogeneic bone marrow transplantation","volume":"50","author":"Nasman","year":"1999","journal-title":"Scandinavian journal of immunology"},{"issue":"4","key":"10.1002\/14651858.CD006501.pub2-BIB0067|cit67","first-page":"181","article-title":"Preventive long term intravenous immunoglobulin infusion in children with acute lymphatic leukemia. II. Zymosan opsonization is decreased and is not increased by IgG infusions","volume":"136","year":"1988","journal-title":"Monatsschroft Kinderheilkunde: Organ der Deutschen Gesellschaft fur Kinderheilkunde"},{"issue":"2","key":"10.1002\/14651858.CD006501.pub2-BIB0068|cit68","first-page":"141","article-title":"The effect of prophylactic intravenous immune globulin on the incidence of septicemia in marrow transplant recipients","volume":"2","author":"Petersen","year":"1987","journal-title":"Bone marrow transplantation"},{"issue":"12","key":"10.1002\/14651858.CD006501.pub2-BIB0069|cit69","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1002\/j.1552-4604.1991.tb03688.x","article-title":"Pharmacokinetics of intravenous immunoglobulin (Gammagard) in bone marrow transplant patients","volume":"31","year":"1991","journal-title":"Journal of clinical pharmacology"},{"issue":"3 Suppl 2","key":"10.1002\/14651858.CD006501.pub2-BIB0070|cit70","first-page":"123","article-title":"Continuous infusion intravenous immunoglobulin is associated with a reduced incidence of infection and achieves higher serum immunoglobulin G levels than intermittent infusion following bone marrow transplantation","volume":"29","year":"1992","journal-title":"Seminars in hematology"},{"issue":"1","key":"10.1002\/14651858.CD006501.pub2-BIB0071|cit71","first-page":"44","article-title":"A controlled trial of long-term administration of intravenous immunoglobulin to prevent late infection and chronic graft-vs.-host disease after marrow transplantation: clinical outcome and effect on subsequent immune recovery","volume":"2","year":"1996","journal-title":"Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation"},{"issue":"1","key":"10.1002\/14651858.CD006501.pub2-BIB0072|cit72","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/S1083-8791(98)90006-4","article-title":"Intravenous immunoglobulin and the risk of hepatic veno-occlusive disease after bone marrow transplantation","volume":"4","year":"1998","journal-title":"Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation"},{"issue":"9","key":"10.1002\/14651858.CD006501.pub2-BIB0073|cit73","first-page":"1328","article-title":"Clinical effects of gamma globulin in severe infections associated with leukemia and malignant lymphoma","volume":"21","year":"1980","journal-title":"[Rinsho ketsueki] The Japanese journal of clinical hematology"},{"key":"10.1002\/14651858.CD006501.pub2-BIB0074|cit74","first-page":"105","article-title":"Prophylaxis against cytomegalovirus infection after BMT with gammaglobulins","volume":"13","year":"1985","journal-title":"Experimental hematology (suppl.17)"},{"issue":"3","key":"10.1002\/14651858.CD006501.pub2-BIB0075|cit75","first-page":"273","article-title":"Efficacy of immune globulin in preventing complications of bone marrow transplantation: a meta-analysis.","volume":"12","author":"Bass","year":"1993","journal-title":"Bone marrow transplantation"},{"issue":"3 Suppl 2","key":"10.1002\/14651858.CD006501.pub2-BIB0076|cit76","first-page":"14","article-title":"Recent advances in the treatment of chronic lymphocytic leukemia: defining the role of intravenous immunoglobulin","volume":"29","author":"Besa","year":"1992","journal-title":"Seminars in hematology"},{"issue":"8905","key":"10.1002\/14651858.CD006501.pub2-BIB0077|cit77","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/S0140-6736(94)90180-5","article-title":"Randomised trial of intravenous immunoglobulin as prophylaxis against infection in plateau-phase multiple myeloma. The UK Group for Immunoglobulin Replacement Therapy in Multiple Myeloma","volume":"343","author":"Chapel","year":"1994","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD006501.pub2-BIB0078|cit78","first-page":"21","article-title":"The use of intravenous immune globulin in multiple myeloma","volume":"97 Suppl 1","author":"Chapel","year":"1994","journal-title":"Clinical and experimental immunology"},{"issue":"8713","key":"10.1002\/14651858.CD006501.pub2-BIB0079|cit79","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/0140-6736(90)92016-B","article-title":"Consensus on IVIG","volume":"336","year":"1990","journal-title":"Lancet"},{"issue":"2","key":"10.1002\/14651858.CD006501.pub2-BIB0080|cit80","doi-asserted-by":"crossref","first-page":"169","DOI":"10.3109\/00365548409087137","article-title":"Current patterns of bacterial infection in myelomatosis","volume":"16","author":"Espersen","year":"1984","journal-title":"Scandinavian journal of infectious diseases"},{"key":"10.1002\/14651858.CD006501.pub2-BIB0081|cit81","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1136\/bmj.2.5257.920","article-title":"Hypogammaglobulinaemia in chronic lymphatic leukaemia","volume":"5257","author":"Fairley","year":"1961","journal-title":"British medical journal"},{"issue":"1 Pt 2","key":"10.1002\/14651858.CD006501.pub2-BIB0082|cit82","first-page":"1408","article-title":"Meta-analysis of immune globulin prophylaxis in transplant recipients for the prevention of symptomatic cytomegalovirus disease","volume":"25","author":"Glowacki","year":"1993","journal-title":"Transplantation proceedings"},{"issue":"1","key":"10.1002\/14651858.CD006501.pub2-BIB0083|cit83","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/j.1399-0012.1994.tb00935.x","article-title":"Use of immune globulin to prevent symptomatic cytomegalovirus disease in transplant recipients--a meta-analysis","volume":"8","author":"Glowacki","year":"1994","journal-title":"Clinical transplantation"},{"issue":"6","key":"10.1002\/14651858.CD006501.pub2-BIB0084|cit84","first-page":"559","article-title":"Intravenous immunoglobulin may lessen all forms of infection in patients receiving allogeneic bone marrow transplantation for acute lymphoblastic leukemia: a pediatric oncology group study","volume":"3","author":"Graham-Pole","year":"1988","journal-title":"Bone marrow transplantation"},{"issue":"2","key":"10.1002\/14651858.CD006501.pub2-BIB0085|cit85","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1182\/blood.V73.2.366.366","article-title":"Crossover study of immunoglobulin replacement therapy in patients with low-grade B-cell tumors","volume":"73","year":"1989","journal-title":"Blood"},{"issue":"5","key":"10.1002\/14651858.CD006501.pub2-BIB0086|cit86","first-page":"499","article-title":"Immune globulin therapy in allogeneic bone marrow transplant: a critical review","volume":"13","author":"Guglielmo","year":"1994","journal-title":"Bone marrow transplantation"},{"key":"10.1002\/14651858.CD006501.pub2-BIB0087|cit87","first-page":"3","article-title":"Chronic lymphocytic leukaemia. Clinical studies based on 189 cases followed for a long time","volume":"18","author":"Hansen","year":"1973","journal-title":"Scandinavian journal of haematology. Supplementum"},{"issue":"9","key":"10.1002\/14651858.CD006501.pub2-BIB0088|cit88","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1111\/j.1365-2362.1993.tb00963.x","article-title":"Effect of IgM-enriched intravenous immunoglobulin (Pentaglobin) on endotoxaemia and anti-endotoxin antibodies in bone marrow transplantation","volume":"23","year":"1993","journal-title":"European journal of clinical investigation"},{"issue":"4","key":"10.1002\/14651858.CD006501.pub2-BIB0089|cit89","doi-asserted-by":"crossref","first-page":"790","DOI":"10.7326\/0003-4819-44-4-790","article-title":"Agammaglobulinemia and chronic lymphocytic leukemia","volume":"44","author":"Jim","year":"1956","journal-title":"Annals of internal medicine"},{"key":"10.1002\/14651858.CD006501.pub2-BIB0090|cit90","first-page":"468","article-title":"Preliminary data of a controlled trial of interavenous hyperimmune globulin in the prevention of cytomegalovirus infection in bone marrow transplant recipients","volume":"XVII","author":"Ernst","year":"1985","journal-title":"Transplantation proceedings"},{"issue":"1","key":"10.1002\/14651858.CD006501.pub2-BIB0091|cit91","first-page":"1405","article-title":"A randomized trial of intravenous hyperimmune globulin for the prevenetion of CMV infections following marrow transplantation: preliminary results","volume":"XV","year":"1983","journal-title":"Transplantation proceedings"},{"issue":"6","key":"10.1002\/14651858.CD006501.pub2-BIB0092|cit92","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/0002-9343(81)90303-X","article-title":"Influence of treatment and response status on infection risk in multiple myeloma","volume":"71","author":"Perri","year":"1981","journal-title":"The American journal of medicine"},{"issue":"3A","key":"10.1002\/14651858.CD006501.pub2-BIB0093|cit93","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/0002-9343(84)90320-6","article-title":"Intravenous immune globulin therapy in hypogammaglobulinemia. A review","volume":"76","author":"Pirofsky","year":"1984","journal-title":"The American journal of medicine"},{"issue":"2","key":"10.1002\/14651858.CD006501.pub2-BIB0094|cit94","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1002\/1097-0142(19880115)61:2<279::AID-CNCR2820610215>3.0.CO;2-4","article-title":"Serum immunoglobulins in B-chronic lymphocytic leukemia. Natural history and prognostic significance","volume":"61","author":"Rozman","year":"1988","journal-title":"Cancer"},{"issue":"1","key":"10.1002\/14651858.CD006501.pub2-BIB0095|cit95","doi-asserted-by":"crossref","first-page":"47","DOI":"10.7326\/0003-4819-96-1-47","article-title":"Biphasic pattern of bacterial infection in multiple myeloma","volume":"96","author":"Savage","year":"1982","journal-title":"Annals of internal medicine"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD006501.pub2-BIB0096|cit96","first-page":"53","article-title":"Reduction in transplant-related complications in patients given intravenous immuno globulin after allogeneic marrow transplantation","volume":"97","author":"Siadak","year":"1994","journal-title":"Clinical and experimental immunology"},{"issue":"3","key":"10.1002\/14651858.CD006501.pub2-BIB0097|cit97","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1053\/bbmt.2002.v8.pm11939601","article-title":"Intravenous immunoglobulin: appropriate indications and uses in hematopoietic stem cell transplantation","volume":"8","author":"Sokos","year":"2002","journal-title":"Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation."},{"key":"10.1002\/14651858.CD006501.pub2-BIB0098|cit98","first-page":"43","article-title":"Immunomodulation in allogeneic marrow transplantation: use of intravenous immune globulin to suppress acute graft-versus-host disease","volume":"104 Suppl 1","author":"Sullivan","year":"1996","journal-title":"Clinical and experimental immunology"},{"issue":"4","key":"10.1002\/14651858.CD006501.pub2-BIB0099|cit99","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1001\/archinte.1973.03650100076014","article-title":"Infections complicating multiple myeloma and chronic lymphocytic leukemia","volume":"132","author":"Twomey","year":"1973","journal-title":"Archives of internal medicine"},{"issue":"5","key":"10.1002\/14651858.CD006501.pub2-BIB0100|cit100","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1182\/blood-2003-01-0255","article-title":"Prior gemtuzumab ozogamicin exposure significantly increases the risk of veno-occlusive disease in patients who undergo myeloablative allogeneic stem cell transplantation","volume":"102","author":"Wadleigh","year":"2003","journal-title":"Blood"},{"issue":"6","key":"10.1002\/14651858.CD006501.pub2-BIB0101|cit101","first-page":"371","article-title":"Advances in the management of infectious complications after bone marrow transplantation","volume":"6","author":"Wingard","year":"1990","journal-title":"Bone marrow transplantation"},{"key":"10.1002\/14651858.CD006501.pub2-BIB0102|cit102","first-page":"296","article-title":"Use of a polyvalent intravenous immunoglobulin or specific cytomegalovirus hyperimmunoglobulin for modification of cytomegalovirus infections and prevention of interstitial pneumonias following bone marrow transplantation","volume":"13","author":"Winston","year":"1985","journal-title":"Immunit?t und Infektion"},{"issue":"1","key":"10.1002\/14651858.CD006501.pub2-BIB0103|cit103","doi-asserted-by":"crossref","first-page":"12","DOI":"10.7326\/0003-4819-106-1-12","article-title":"Intravenous immune globulin for prevention of cytomegalovirus infection and interstitial pneumonia after bone marrow transplantation","volume":"106","author":"Winston","year":"1987","journal-title":"Annals of internal medicine"},{"issue":"1","key":"10.1002\/14651858.CD006501.pub2-BIB0104|cit104","doi-asserted-by":"crossref","first-page":"12","DOI":"10.7326\/0003-4819-106-1-12","article-title":"Intravenous immune globulin for prevention of cytomegalovirus infection and interstitial pneumonia after bone marrow transplantation","volume":"106","author":"Winston","year":"1987","journal-title":"Annals of internal medicine"},{"key":"10.1002\/14651858.CD006501.pub2-BIB0105|cit105","doi-asserted-by":"crossref","first-page":"S776","DOI":"10.1093\/clinids\/12.Supplement_7.S776","article-title":"Cytomegalovirus infections after allogeneic bone marrow transplantation","volume":"12 Suppl 7","author":"Winston","year":"1990","journal-title":"Reviews of infectious diseases"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/14651858.CD006501.pub2\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,14]],"date-time":"2025-04-14T00:19:38Z","timestamp":1744589978000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD006501.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Haematology Group","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2008,10,8]]},"references-count":105,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2024,3]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd006501.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,10,8]]}}}